LifeScience Emerging Biotech
GC Biopharma, a South Korean biopharmaceutical company, announced on Jun. 1st that it has successfully obtained final approval from the Indonesia...
June 02, 2023 | News
Dr. Nie Junwei, General Manager of Life Science Division, Vazyme, and Mr. George Ge, General Manager of Azenta China, witnessed by Dr. Cao Lin, C...
June 01, 2023 | News
Beijing Luzhu Biotechnology Co., Ltd. ("Luzhu Biotechnology" or the "Company", together with its subsidiaries, the "Group", stock code: 02480.HK), a l...
May 31, 2023 | News
Under an exclusive licensing agreement, Amplo Biotechnology has gained access to AAV-ColQ data developed by Professor Kinji Ohno's laboratory at&...
May 30, 2023 | News
FivepHusion, an advanced clinical-stage biotechnology company, today announced its collaboration with Treehill Partners, a New York-based strategic an...
May 29, 2023 | News
Daewoong Pharmaceutical (CEO Lee Chang-jae and Jeon Sengho) announced on the 25th that the molecular mechanism behind safety and efficacy of Bersiporo...
May 26, 2023 | News
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional pro...
May 25, 2023 | News
SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company's CE...
May 24, 2023 | News
The over 200 million RMB collaboration will allow GQ to leverage TOBio's expertise in CMC and commercial manufacturing to advance its pharmaceutica...
May 23, 2023 | News
TVM Capital Healthcare, a global specialist healthcare private equity firm headquartered in Dubai and Singapore, is pleased to announce an i...
May 23, 2023 | News
Boan Biotech announced today that its BA1202, a CEACAM5 (CEA)/CD3 bispecific antibody, has been approved for a clinical trial by the Center for Drug Evalua...
May 17, 2023 | News
With +80 US/EU peer reviewed publications, the oCelloScope is a one-of-a-kind workhorse in many microbial applications. In AST,...
May 17, 2023 | News
Establishing this local office comes after TVM Capital Healthcare successfully expanded its portfolio company Cambridge Medical and Rehabilitation Center f...
May 16, 2023 | News
HMBD-011 is a potentially first-in-class anti-VH4-34 antibody developed for treatment of VH4-34+ antibody-driven pathogenesis in lupus and cold agglutini...
May 09, 2023 | News
Most Read
Bio Jobs
News